Abstract
11046Background: There are currently no FDA approved targeted therapies for sarcomas except GIST. Complicating this is the extreme diversity, heterogeneity, and rarity of these neoplasms. Few thera...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
